öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÌÆÈιâ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º252

ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺ
ËùÊôԺϵ£º
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÁÙ´²¼ìÑéÕï¶ÏѧÁÙ´²ÊäѪѧ¼ìÑé
Ñо¿ÁìÓò£º ÁÙ´²¼ìÑéÕï¶ÏѧÁÙ´²ÊäѪѧ¼ìÑé [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºtrga@sina.com


¸öÈ˼òÊö :
¹¤×÷¾­Àú£º1988Äê7ÔÂÖÁ1993Äê8Ô£¬ÁÙ´²Ñ§Ôº¼ìÑé¿Æ¼ìÑ鼼ʿ 1993Äê9ÔÂÖÁ1997Äê11Ô£¬ÁÙ´²Ñ§Ôº¼ìÑé¿Æ¼ìÑ鼼ʦ 1997Äê12ÔÂÖÁ2006Äê11Ô£¬ÁÙ´²Ñ§Ôº¼ìÑé¿ÆÖ÷¹Ü¼¼Ê¦ 2006Äê12ÔÂÖÁ2011Äê11Ô£¬ÁÙ´²Ñ§ÔºÊäѪ¿Æ¸±Ö÷Èμ¼Ê¦£¬ÈοƸ±Ö÷ÈΡ¢Ö÷ÈÎ 2011Äê12Ô£¬ÁÙ´²Ñ§ÔºÊäѪ¿ÆÖ÷Èμ¼Ê¦£¬ÈÎÊäѪ¿ÆÖ÷ÈÎ
Éç»áÖ÷Òª¼æÖ°£º¹ãÎ÷ÁÙ´²ÊäѪÖÊÁ¿¿ØÖÆÖÐÐĸ±Ö÷ÈÎ ¹ãÎ÷ ҽʦЭ»áÊäѪ¿Æҽʦ·Ö»á¸±»á³¤ ¹ãÎ÷ÊäѪЭ»áÀíÊ ¹ãÎ÷ҽѧ»áÁÙ´²ÊäѪ¿Æѧ·Ö»á³£

¿ÆÑй¤×÷ :
ѧÊõÂÛÎÄ 1¡¢ÌÆÈι⣬»ÆÕÕºÓ£¬»ÆÇ죬µÈ.ÀÏÄê¹ÚÐIJ¡»¼ÕßPÑ¡ÔñËØÓëѪС°å¼ì²âµÄÁÙ´²ÒâÒå[J].ÖÐÀÏÄêÐÄÄÔѪ¹Ü²¡ÔÓÖ¾£¬2009£¬11£¨6£©£º646. 2¡¢ÌÆÈι⣬ԬÎý»ª£¬ÁúÏÔ¿Æ£¬µÈ.ʳ¹Ü°©»¼ÕßÍâÖÜѪÇåIL8¡¢IL18ˮƽµÄ²â¶¨[J].¼ìÑéҽѧ£¬2009£¬24£¨2£©£º117-119. 3¡¢ÌÆÈι⣬»ÆÇ죬ÀîÈÙÑÕ£¬µÈ.΢ÖùÄý½º¿¨Ê½·¨ºÍ´«Í³ÊԹܷ¨¼ì²âÐÂÉú¶ùÈÜѪ²¡3Ïî½á¹ûµÄ±È½Ï[J].ÖйúÊäѪÔÓÖ¾£¬2009£¬22£¨11£©£º913-914. 4¡¢ÌÆÈι⣬лÀöÁᣬ»ÆÇ죬µÈ.Ôвú¸¾ÑªÇåºÍÈéÖ­¼°ÐÂÉú¶ùÆêѪÖÐÊäѪ´«²¥²¡¶¾µÄ¸ÐȾ״¿ö[J].ÖйúʵÑéÕï¶Ïѧ£¬2009 £¬13£¨9 £©£º1274-1275. 5¡¢ÌÆÈι⣬ΤҶÉú£¬»ÆÕÕºÓ£¬µÈ.ת»¯Éú³¤Òò×Ó¦Â1»ùÒò+ 869T/C¶à̬ÐÔÓëÔ­·¢ÐÔ¸ßѪѹµÄ¹Øϵ[J].ÁÙ´²¼ìÑéÔÓÖ¾£¬2009£¬27£¨4£©£º270-271. 6¡¢ÌÆÈι⣬ΤҶÉú£¬³ÂºêÃ÷£¬µÈ.ʳ¹Ü°©»¼ÕßѪÇåTGF¦Â1ˮƽµÄ¼à²â¼°ÁÙ´²ÒâÒå[J].ÖØÇìҽѧ£¬2010£¬39£¨3£©£º322-323. 7¡¢ÌÆÈι⣬ΤҶÉú£¬Î¤²Ê³É£¬µÈ.ת»¯Éú³¤Òò×Ó¦Â1 »ùÒò¶à̬ÐÔÓëʳ¹Ü°©µÄ¹Øϵ[J].ÖйúʵÑéÕï¶Ïѧ£¬2010£¬14£¨3£©£º415-418. 8¡¢ÌÆÈι⣬ΤµÀÎÄ£¬ÂÀ½¨Éú£¬µÈ.ת»¯Éú³¤Òò×Ӧ£±»ùÒò£­ 509C £¯T¶à̬ÐÔÓë½áÖ±³¦°©¹ØϵµÄÑо¿[J].ÖйúʵÑéÕï¶Ïѧ£¬2012£¬16£¨8£©£º1398-1400. 9¡¢Ren-Guang Tang, Yong-Zhi Huang , Li-Min Yao, et al.Polymorphisms of transforming growth factor beta 1 (RS#** and RS#**) and esophageal squamous cell carcinoma among Zhuangese population, China[J].Gene, 2013,512£º1-5. 10¡¢ÌÀÀöϼ£¬Î¤ÖÐÊ¢£¬ÁúÏÔ¿Æ£¨Í¨Ñ¶×÷Õߣ©£¬µÈ.¶àÖØÄÍÒ©¾úÒ½Ôº¸ÐȾ¼à²â¼°ÄÍÒ©ÐÔ·ÖÎö[J].ÖйúÀÏÄêѧÔÓÖ¾£¬2014£¬34£¨13£©£º3539-3541. 11¡¢ÌÆÈι⣬ΤµÀÎÄ£¬ÂÀ½¨Éú£¬µÈ.ת»¯Éú³¤Òò×Ó¦Â1 »ùÒò¶à̬ÐÔÓë½áÖ±³¦°©µÄ¹Øϵ[J]. ÖйúÀÏÄêѧÔÓÖ¾£¬2014£¬34£¨14£©£º33847-3849.

½ÌÓý±³¾° :
1988Äê7Ô£¬¹ãÎ÷ÎÀÉúѧУ £»2005Äê7Ô£¬ÓÒ½­Ãñ×åҽѧԺ£¬»ñҽѧѧʿѧλ£» 2013Äê7Ô£¬ôßÄÏ´óѧÑо¿ÉúѧÀú